Exact Sciences Corporation (EXAS) - Financial and Strategic SWOT Analysis Review

Date: June 1, 2016
Pages: 51
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E8E56FC261CEN
Leaflet:

Download PDF Leaflet

Exact Sciences Corporation (EXAS) - Financial and Strategic SWOT Analysis Review
Exact Sciences Corporation (EXAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Exact Sciences Corporation (Exact) is a molecular diagnostics company that focuses on the early detection and prevention of various forms of cancer. The company’s product portfolio includes screening test technologies such as Cologuard test, a non-invasive stool-based deoxyribonucleic acid screening technology product to detect DNA markers. It is used to detect presence of colorectal pre-cancer and cancer. Exact’s Cologuard test also includes protein marker to detect blood in the stool, utilizing an antibody based fecal immunochemical test. It intends to maximize its patent portfolio with other blood-based screening and diagnostics tests to detect esophageal, pancreatic and lung cancers. The company operates a laboratory facility to process Cologuard tests in Madison, Wisconsin. Exact is headquartered in Madinson, Wisconsin, the US.

Exact Sciences Corporation Key Recent Developments

Feb 24, 2016: Exact Sciences Reports Fourth Quarter and Full Year 2015 Results
Jan 25, 2016: Exact Sciences announces appointment of John A. Fallon, M.D., to company's board of directors
Jan 11, 2016: Exact Sciences Announces Preliminary Fourth Quarter and Full Year 2015 Results
Dec 17, 2015: Exact Sciences Names John Bakewell Chief Financial Officer
Oct 29, 2015: Cologuard Growth Trajectory Increases to 34,000 Completed Tests, Generates $12.6M in Revenue in Third Quarter 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Exact Sciences Corporation - Key Facts
Exact Sciences Corporation - Key Employees
Exact Sciences Corporation - Key Employee Biographies
Exact Sciences Corporation - Major Products and Services
Exact Sciences Corporation - Medical Equipment Pipeline Products Data
Exact Sciences Corporation Pipeline Products by Equipment Type
Exact Sciences Corporation Pipeline Products by Development Stage
Exact Sciences Corporation - History
Exact Sciences Corporation - Company Statement
Exact Sciences Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Exact Sciences Corporation - Business Description
Exact Sciences Corporation - Corporate Strategy
Exact Sciences Corporation - SWOT Analysis
SWOT Analysis - Overview
Exact Sciences Corporation - Strengths
Strength - Focused Research & Development
Strength - Novel Stool Based DNA Screening Technology
Strength - Core Product: Cologuard
Exact Sciences Corporation - Weaknesses
Weakness - History of Losses
Exact Sciences Corporation - Opportunities
Opportunity - Strategic Agreements
Opportunity - Potential Market for Colorectal Cancer
Exact Sciences Corporation - Threats
Threat - Uncertain R&D Outcomes
Threat - Competitive Pressures
Threat - Stringent Government Regulations
Exact Sciences Corporation - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Exact Sciences Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Exact Sciences Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Exact Sciences Corporation, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 24, 2016: Exact Sciences Reports Fourth Quarter and Full Year 2015 Results
Jan 25, 2016: Exact Sciences announces appointment of John A. Fallon, M.D., to company's board of directors
Jan 11, 2016: Exact Sciences Announces Preliminary Fourth Quarter and Full Year 2015 Results
Dec 17, 2015: Exact Sciences Names John Bakewell Chief Financial Officer
Oct 29, 2015: Cologuard Growth Trajectory Increases to 34,000 Completed Tests, Generates $12.6M in Revenue in Third Quarter 2015
Jul 20, 2015: Exact Sciences Highlights Cologuard’s Positive Launch Trajectory in Second Quarter 2015
May 04, 2015: Exact Sciences Reports Strong Growth Trajectory for Cologuard in First-Quarter 2015
Feb 24, 2015: Exact Sciences Reports Fourth-Quarter and Full-Year 2014 Financial Results
Feb 23, 2015: WEDC Tax Credits to Support Exact Sciences' Growth in Wisconsin
Feb 11, 2015: Exact Sciences Names Michael S. Wygza to its Board of Directors

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Exact Sciences Corporation, Key Facts
Exact Sciences Corporation, Key Employees
Exact Sciences Corporation, Key Employee Biographies
Exact Sciences Corporation, Major Products and Services
Exact Sciences Corporation Number of Pipeline Products by Equipment Type
Exact Sciences Corporation Pipeline Products by Equipment Type
Exact Sciences Corporation Number of Pipeline Products by Development Stage
Exact Sciences Corporation Pipeline Products by Development Stage
Exact Sciences Corporation, History
Exact Sciences Corporation, Subsidiaries
Exact Sciences Corporation, Key Competitors
Exact Sciences Corporation, Ratios based on current share price
Exact Sciences Corporation, Annual Ratios
Exact Sciences Corporation, Interim Ratios
Exact Sciences Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Exact Sciences Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Exact Sciences Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Exact Sciences Corporation Pipeline Products by Equipment Type
Exact Sciences Corporation Pipeline Products by Development Stage
Exact Sciences Corporation, Performance Chart (2011 - 2015)
Exact Sciences Corporation, Ratio Charts
Exact Sciences Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
Exact Sciences Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Exact Sciences Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Quest Diagnostics Incorporated
Applied Proteomics, Inc.
EDP Biotech Corporation
Epigenomics AG
GeneNews Limited
Everist Genomics, Inc.
Skip to top


Ask Your Question

Exact Sciences Corporation (EXAS) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: